Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

632 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.
Gotti E, Perico N, Gaspari F, Cattaneo D, Lesti MD, Ruggenenti P, Segoloni G, Salvadori M, Rigotti P, Valente U, Donati D, Sandrini S, Federico S, Sparacino V, Mourad G, Bosmans JL, Dimitrov BD, Iordache BE, Remuzzi G. Gotti E, et al. Among authors: cattaneo d. Transplant Proc. 2005 Jun;37(5):2037-40. doi: 10.1016/j.transproceed.2005.03.096. Transplant Proc. 2005. PMID: 15964332 Clinical Trial.
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial.
Perico N, Ruggenenti P, Gotti E, Gaspari F, Cattaneo D, Valente U, Salvadori M, Segoloni G, Donati D, Sandrini S, Ganeva M, Dimitrov BD, Remuzzi G; MY.S.S. Study Investigators. Perico N, et al. Among authors: cattaneo d. Kidney Int. 2004 Mar;65(3):1084-90. doi: 10.1111/j.1523-1755.2004.00471.x. Kidney Int. 2004. PMID: 14871429 Free article. Clinical Trial.
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.
Ruggenenti P, Perico N, Gotti E, Cravedi P, D'Agati V, Gagliardini E, Abbate M, Gaspari F, Cattaneo D, Noris M, Casiraghi F, Todeschini M, Cugini D, Conti S, Remuzzi G. Ruggenenti P, et al. Among authors: d agati v, cattaneo d. Transplantation. 2007 Oct 27;84(8):956-64. doi: 10.1097/01.tp.0000284808.28353.2c. Transplantation. 2007. PMID: 17989600 Clinical Trial.
Nephrotoxic aspects of cyclosporine.
Cattaneo D, Perico N, Gaspari F, Remuzzi G. Cattaneo D, et al. Transplant Proc. 2004 Mar;36(2 Suppl):234S-239S. doi: 10.1016/j.transproceed.2004.01.011. Transplant Proc. 2004. PMID: 15041344 Review.
632 results